Advanced search
Add to list

Two years follow-up results after rituximab treatment (baseline and month 6) in patients with 'early' systemic sclerosis with diffuse skin involvement

Vanessa Smith (UGent) , YVES PIETTE (UGent) , Saskia Decuman (UGent) , Jens Van Praet (UGent) , Ellen De Schepper and Filip De Keyser (UGent)
(2011) ARTHRITIS AND RHEUMATISM. 63(10, suppl.). p.S566-S566
Author
Organization

Citation

Please use this url to cite or link to this publication:

MLA
Smith, Vanessa, YVES PIETTE, Saskia Decuman, et al. “Two Years Follow-up Results After Rituximab Treatment (baseline and Month 6) in Patients with ‘Early’ Systemic Sclerosis with Diffuse Skin Involvement.” Arthritis and Rheumatism. Vol. 63. 2011. S566–S566. Print.
APA
Smith, V., PIETTE, Y., Decuman, S., Van Praet, J., De Schepper, E., & De Keyser, F. (2011). Two years follow-up results after rituximab treatment (baseline and month 6) in patients with “early” systemic sclerosis with diffuse skin involvement. ARTHRITIS AND RHEUMATISM (Vol. 63, pp. S566–S566). Presented at the 75th Annual scientific meeting of the American College of Rheumatology ; 46th Annual scientific meeting of the Association of Rheumatology Health Professionals.
Chicago author-date
Smith, Vanessa, YVES PIETTE, Saskia Decuman, Jens Van Praet, Ellen De Schepper, and Filip De Keyser. 2011. “Two Years Follow-up Results After Rituximab Treatment (baseline and Month 6) in Patients with ‘Early’ Systemic Sclerosis with Diffuse Skin Involvement.” In Arthritis and Rheumatism, 63:S566–S566.
Chicago author-date (all authors)
Smith, Vanessa, YVES PIETTE, Saskia Decuman, Jens Van Praet, Ellen De Schepper, and Filip De Keyser. 2011. “Two Years Follow-up Results After Rituximab Treatment (baseline and Month 6) in Patients with ‘Early’ Systemic Sclerosis with Diffuse Skin Involvement.” In Arthritis and Rheumatism, 63:S566–S566.
Vancouver
1.
Smith V, PIETTE Y, Decuman S, Van Praet J, De Schepper E, De Keyser F. Two years follow-up results after rituximab treatment (baseline and month 6) in patients with “early” systemic sclerosis with diffuse skin involvement. ARTHRITIS AND RHEUMATISM. 2011. p. S566–S566.
IEEE
[1]
V. Smith, Y. PIETTE, S. Decuman, J. Van Praet, E. De Schepper, and F. De Keyser, “Two years follow-up results after rituximab treatment (baseline and month 6) in patients with ‘early’ systemic sclerosis with diffuse skin involvement,” in ARTHRITIS AND RHEUMATISM, Chicago, IL, USA, 2011, vol. 63, no. 10, suppl., pp. S566–S566.
@inproceedings{1974782,
  articleno    = {abstract 1448},
  author       = {Smith, Vanessa and PIETTE, YVES and Decuman, Saskia and Van Praet, Jens and De Schepper, Ellen and De Keyser, Filip},
  booktitle    = {ARTHRITIS AND RHEUMATISM},
  issn         = {0004-3591},
  language     = {eng},
  location     = {Chicago, IL, USA},
  number       = {10, suppl.},
  pages        = {abstract 1448:S566--abstract 1448:S566},
  title        = {Two years follow-up results after rituximab treatment (baseline and month 6) in patients with 'early' systemic sclerosis with diffuse skin involvement},
  volume       = {63},
  year         = {2011},
}

Web of Science
Times cited: